Blog | Veristat

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Sign Up Today

Regulatory Submissions

3 min read

Monthly FDA Guidance and Regulatory News Review - April 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

READ MORE

1 min read

Staying the Course: What FDA Staffing Reductions Mean for Drug Development Today

The U.S. Food and Drug Administration (FDA) is undergoing significant change. Recent announcements have highlighted budget constraints, hiring freezes, and reductions in force (RIFs) across federal health agencies, including the FDA. These shifts have...

READ MORE

2 min read

Unlocking the Promise of Radiopharmaceuticals: Safety, Strategy & Innovation in Clinical Trials

We’re hearing more and more about the value of radiopharmaceuticals in medicine today—but what does it take to ensure their safe and effective development throughout a clinical trial?

READ MORE

2 min read

Building Confidence in RWE: Delivering Smarter Regulatory Strategies

Real-world evidence (RWE) offers the potential to serve as a valuable tool in regulatory decision-making, offering insights derived from the real world that can complement traditional clinical trials. By capturing data from diverse sources such as...

READ MORE

3 min read

The Evolving Landscape of Radiopharmaceuticals in Oncology Research

Radiopharmaceuticals have been around for decades, but their role in oncology is expanding rapidly. With the increasing focus on targeted therapies, the ability to precisely deliver radiation to tumors through radiopharmaceutical therapy is becoming an...

READ MORE

4 min read

Monthly FDA Guidance and Regulatory News Review - March 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

READ MORE

1 min read

Data Analysis Excellence: The Backbone of Successful Marketing Applications

In the complex landscape of marketing application preparation, data analysis stands as a critical cornerstone that can either propel a submission forward or become its greatest challenge. With shifting deadlines, potential delays in data receipt, and the...

READ MORE

3 min read

Veristat Expands Global Regulatory Expertise

Meet Daphne Smyth, Vice President, Global Head of Regulatory Affairs

READ MORE

1 min read

The Human Factor: Why Team Integration Makes or Breaks Marketing Applications

In the complex world of new drug applications (NDAs) and marketing authorization applications (MAAs), success often hinges not on technical expertise alone, but on how well teams work together. While each submission brings its own unique challenges, one...

READ MORE

1 min read

Evaluating Adaptive Trials: Do They Align with Your Study’s Goals and Requirements?

Innovative clinical trial approaches, including adaptive study designs, can play a key role in improving the efficiency of new drug development within biotech and pharma clinical research.

READ MORE